Gemcitabine and docetaxel as second-line chemotherapy in elderly patients with metastatic urothelial carcinoma: a retrospective analysis

Gemcitabine and docetaxel as second-line chemotherapy in elderly patients with metastatic urothelial carcinoma: a retrospective analysis

Taku Naiki,1 Keitaro Iida,1 Toshiki Etani,1 Takashi Nagai,2 Yutaro Tanaka,1 Yosuke Sugiyama,3 Ryosuke Ando,1 Shuzo Hamamoto,1 Rika Banno,4 Daisuke Nagata,4 Noriyasu Kawai,1 Takahiro Yasui1 1Department of Nephro-Urology, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan; 2Dep...

Full description

Bibliographic Details
Main Authors: Naiki T, Iida K, Etani T, Nagai T, Tanaka Y, Sugiyama Y, Ando R, Hamamoto S, Banno R, Nagata D, Kawai N, Yasui T
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:Cancer Management and Research
Subjects:
gemcitabine and docetaxel
elderly patients
second-line
metastatic urothelial carcinoma
Online Access:https://www.dovepress.com/gemcitabine-and-docetaxel-as-second-line-chemotherapy-in-elderly-patie-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/gemcitabine-and-docetaxel-as-second-line-chemotherapy-in-elderly-patie-peer-reviewed-article-CMAR

Similar Items